Pain Research Center, MRB 611/BWH, 75 Francis Street, Boston, MA 02115-6110, USA.
Anesth Analg. 2013 Mar;116(3):694-702. doi: 10.1213/ANE.0b013e31827aed25. Epub 2013 Feb 11.
The potency and efficacy of local anesthetics injected clinically for peripheral nerve block depends strongly on the rate of neural drug uptake. However, because diffusion into surrounding tissues and removal by the vascular system are major factors in the overall distribution of lidocaine in vivo, true kinetics of drug/neural tissue interactions must be studied in the absence of those confounding factors.
Uptake: Ensheathed or desheathed isolated rat sciatic nerves were exposed to [(14)C]-lidocaine for 0 to 180 minutes and then removed and the lidocaine content of nerve and sheath analyzed. Washout: Isolated nerves were soaked in [(14)C]-lidocaine for 60 minutes and then placed in lidocaine-free solution for 0 to 30 minutes, with samples removed at different times to assess the drug content. Experimental variables included the effects of the ensheathing epineurium, lidocaine concentration, pH, presence of CO(2)-bicarbonate, and incubation duration.
The equilibrium uptake of lidocaine increased with incubation time, concentration, and the fraction of molecules in the nonionized form. The uptake rate was unaffected by drug concentration, but was about halved by the presence of the epineurial sheath, with the washout rate slowed less. Slight alkalinization, from pH 6.8 to pH 7.4, by bicarbonate-CO(2) buffer or a nonbicarbonate buffer, enhanced the neural uptake, and to the same degree. The washout of lidocaine was faster after shorter incubations at high concentrations than when equal amounts of lidocaine were taken up after long incubations at low lidocaine concentrations.
Lidocaine enters a nerve by a process other than free diffusion, through an epineurial sheath that is a slight obstacle. Given the rapid entry in vitro compared with the much smaller and transient content measured in vivo, it seems highly unlikely that lidocaine equilibrates with the nerve during a peripheral blockade.
临床用于外周神经阻滞的局部麻醉剂的效力和疗效在很大程度上取决于神经药物摄取的速度。然而,由于扩散到周围组织和被血管系统清除是利多卡因在体内总体分布的主要因素,因此必须在没有这些混杂因素的情况下研究药物/神经组织相互作用的真实动力学。
摄取:将有鞘或无鞘的分离大鼠坐骨神经暴露于[(14)C]-利多卡因 0 至 180 分钟,然后取出并分析神经和鞘中的利多卡因含量。冲洗:将分离的神经在[(14)C]-利多卡因中浸泡 60 分钟,然后置于无利多卡因溶液中 0 至 30 分钟,在不同时间取出样品以评估药物含量。实验变量包括鞘的影响、利多卡因浓度、pH 值、CO(2)-碳酸氢盐的存在以及孵育时间。
利多卡因的平衡摄取随孵育时间、浓度和非离子化形式的分子分数增加而增加。摄取速率不受药物浓度的影响,但存在神经外膜鞘时约减半,洗脱速率降低较少。用碳酸氢盐-CO(2)缓冲液或非碳酸氢盐缓冲液将 pH 值从 6.8 轻微碱化至 7.4,可增强神经摄取,程度相同。在高浓度下进行较短孵育后,利多卡因的洗脱速度比在低浓度下进行长时间孵育后摄取等量利多卡因时更快。
利多卡因通过穿过轻微障碍的神经外膜鞘的过程而不是自由扩散进入神经。鉴于体外的快速进入与体内测量的小得多且短暂的含量相比,利多卡因在周围阻滞期间与神经达到平衡的可能性似乎非常小。